YSB Inc. (FRA:B1S)

Market Cap	428.34M -15.0%
Revenue (ttm)	2.55B +17.1%
Net Income	18.63M +409.7%
EPS	0.03 +373.0%
Shares Out	n/a
PE Ratio	23.00
Forward PE	n/a
Dividend	0.01 (1.56%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	n/a
Open	0.5650
Previous Close	0.5900
Day's Range	0.5650 - 0.5650
52-Week Range	0.3980 - 1.2900
Beta	n/a
RSI	57.02
Earnings Date	n/a

About YSB Inc.

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2015
• Employees: 6,950
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: B1S

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY